Sign Up to like & get
recommendations!
0
Published in 2018 at "Current Opinion in Allergy and Clinical Immunology"
DOI: 10.1097/aci.0000000000000479
Abstract: Purpose of review In this review, we sought to outline many of the recent evidences about the available clinical trials in which biologic agents [i.e. omalizumab (OMA)] were associated as add-on to allergen-specific immunotherapy (AIT).…
read more here.
Keywords:
immunotherapy add;
immunotherapy;
allergen immunotherapy;
add biologic ... See more keywords